As research progresses, personalized medicine approaches, novel drug formulations, and combination therapies will shape the future of obesity pharmacotherapy
The innovation of using the nasal membrane for fast uptake (as seen in options like Pressureze Nasal Spray) presents an appealing alternative for those who prefer to avoid injections
Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and constipation, which are usually mild to moderate and tend to diminish over time
Retatrutide is a triple GLP-1, GIP, and glucagon receptor agonist under clinical investigation for obesity, but it is not licensed by the MHRA or EMA in the UK
For maintenance , monthly treatments often provide sufficient ongoing support to keep your detoxification pathways functioning optimally
There is no permanent hair loss with a pure telogen effluvium that has no hereditary component